2025 Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization

Authors:

Top Cited Papers
Open Access
Abstract
Monoclonal antibodies (mAbs) are among the most successful therapeutic modalities, with over 200 marketed products and nearly 1400 candidates in clinical development.1 While high-affinity binding r...
Funding Information
  • Ginkgo Bioworks, Inc

This publication has 34 references indexed in Scilit: